Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

You seem to be using a wider screen, would you like to enable a wider viewing experience on this page?

OrderYOYO – Presentation Half-year report 2024

By Michael FriisHead of Equities
OrderYOYO

You can already now sign up for the event and send in your questions. You don’t have to participate live to send in questions for the event.

OrderYOYO will release its Half-year report 2024 on the 22 August 2024. The company’s management will present the results in a virtual live event with a Q&A session on 26 August 2024 at 11.00. Besides the financial results, you can get an update on recent business developments as well as insights about the current market conditions.

Previous to the half year result OrderYOYO has released a trading update for Q2 2024. The trading update showed continued growth momentum both on the topline and earnings and resulted in the third guidance upgrade since late 2023. The updated guidance for 2024 is December 2024 ARR of DKK 325-335m (DKK 296m by the end of 2023), full-year 2024 net revenue of DKK 290-300m (DKK 254m in 2023), full-year 2024 EBITDA guidance of DKK 45-50 m (DKK 25.6m in 92023), and full-year cash EBITDA guidance of DKK 17-22m (DKK 0.1m in 2023).

OrderYOYO is a Danish Software-as-a-Service (SaaS) company that provides takeaway restaurants with all the necessary software to serve their customers, including online ordering, payment, marketing, and business management solutions. The software enables restaurants to have their own-branded online presence directly to consumers instead of via food portals.

Disclaimer: HC Andersen Capital receives payment from OrderYOYO for a Corporate Visibility/Digital IR subscription agreement. /Michael Friis 15.38, 6 August 2024.

Recent videos

AKTIER MED FRIIS - UGE 2 2026
09.01.2026, 12.00
HCA Morgenbørs 09/01 - Futures peger op i Europa og fokus på afgørelse om Trumps tariffer
09.01.2026, 09.28 Gubra
Herantis Pharma Plc, Phase 1b biomarker data webcast
08.01.2026, 11.00 Herantis Pharma
HCA Morgenbørs 08/01 - Røde futures og fokus på kursmålsjusteringer
08.01.2026, 09.18 Novo Nordisk
HCA Morgenbørs 07/01 - Vi ser ind i en blandet udvikling på de globale futures-markeder med Europa i plus og USA i minus
07.01.2026, 09.58 RTX
View all videos
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.